vs
Side-by-side financial comparison of Boxlight Corp (BOXL) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $29.3M, roughly 1.6× Boxlight Corp). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -21.1%, a 16.3% gap on every dollar of revenue. On growth, Boxlight Corp posted the faster year-over-year revenue change (-19.2% vs -47.3%). Over the past eight quarters, IRONWOOD PHARMACEUTICALS INC's revenue compounded faster (-20.2% CAGR vs -23.1%).
Boxlight Corp is a global provider of interactive technology solutions, including interactive flat panel displays, projectors, collaborative software, and classroom technology accessories. It primarily serves K-12 and higher education institutions, as well as corporate and government customers across North America, Europe, and Asia Pacific, focusing on enhancing learning and work collaboration efficiency.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
BOXL vs IRWD — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $29.3M | $47.7M |
| Net Profit | $-6.2M | $-2.3M |
| Gross Margin | 29.1% | — |
| Operating Margin | -13.4% | 14.3% |
| Net Margin | -21.1% | -4.8% |
| Revenue YoY | -19.2% | -47.3% |
| Net Profit YoY | -102.0% | -200.9% |
| EPS (diluted) | $-1.88 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $47.7M | ||
| Q3 25 | $29.3M | $122.1M | ||
| Q2 25 | $30.9M | $85.2M | ||
| Q1 25 | — | $41.1M | ||
| Q4 24 | $24.0M | $90.5M | ||
| Q3 24 | $36.3M | $91.6M | ||
| Q2 24 | $38.5M | $94.4M | ||
| Q1 24 | $37.1M | $74.9M |
| Q4 25 | — | $-2.3M | ||
| Q3 25 | $-6.2M | $40.1M | ||
| Q2 25 | $-4.7M | $23.6M | ||
| Q1 25 | — | $-37.4M | ||
| Q4 24 | $-16.7M | $2.3M | ||
| Q3 24 | $-3.1M | $3.6M | ||
| Q2 24 | $-1.5M | $-860.0K | ||
| Q1 24 | $-7.1M | $-4.2M |
| Q4 25 | — | — | ||
| Q3 25 | 29.1% | — | ||
| Q2 25 | 35.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 30.6% | — | ||
| Q3 24 | 33.8% | — | ||
| Q2 24 | 37.7% | — | ||
| Q1 24 | 34.5% | — |
| Q4 25 | — | 14.3% | ||
| Q3 25 | -13.4% | 61.8% | ||
| Q2 25 | -12.7% | 53.2% | ||
| Q1 25 | — | -70.7% | ||
| Q4 24 | -67.6% | 34.8% | ||
| Q3 24 | -2.4% | 28.0% | ||
| Q2 24 | 3.2% | 26.5% | ||
| Q1 24 | -9.7% | 14.7% |
| Q4 25 | — | -4.8% | ||
| Q3 25 | -21.1% | 32.8% | ||
| Q2 25 | -15.3% | 27.7% | ||
| Q1 25 | — | -90.9% | ||
| Q4 24 | -69.6% | 2.5% | ||
| Q3 24 | -8.4% | 4.0% | ||
| Q2 24 | -3.8% | -0.9% | ||
| Q1 24 | -19.1% | -5.6% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | $-1.88 | $0.23 | ||
| Q2 25 | $-1.53 | $0.14 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | $-87.29 | $0.03 | ||
| Q3 24 | $-1.72 | $0.02 | ||
| Q2 24 | $-0.92 | $-0.01 | ||
| Q1 24 | $-0.76 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.8M | $215.5M |
| Total DebtLower is stronger | $36.7M | — |
| Stockholders' EquityBook value | $-19.5M | $-261.8M |
| Total Assets | $99.6M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $215.5M | ||
| Q3 25 | $11.8M | $140.4M | ||
| Q2 25 | $7.6M | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | $8.0M | $88.6M | ||
| Q3 24 | $10.5M | $88.2M | ||
| Q2 24 | $7.5M | $105.5M | ||
| Q1 24 | $11.8M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | $36.7M | $199.5M | ||
| Q2 25 | $39.0M | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | $37.1M | $199.0M | ||
| Q3 24 | $38.8M | $198.8M | ||
| Q2 24 | $40.3M | $198.6M | ||
| Q1 24 | $38.5M | $398.3M |
| Q4 25 | — | $-261.8M | ||
| Q3 25 | $-19.5M | $-264.2M | ||
| Q2 25 | $-20.6M | $-308.2M | ||
| Q1 25 | — | $-334.1M | ||
| Q4 24 | $-12.9M | $-301.3M | ||
| Q3 24 | $6.5M | $-311.3M | ||
| Q2 24 | $7.5M | $-321.7M | ||
| Q1 24 | $9.1M | $-330.5M |
| Q4 25 | — | $396.9M | ||
| Q3 25 | $99.6M | $396.1M | ||
| Q2 25 | $99.2M | $342.9M | ||
| Q1 25 | — | $327.2M | ||
| Q4 24 | $115.3M | $350.9M | ||
| Q3 24 | $142.9M | $389.5M | ||
| Q2 24 | $141.3M | $395.6M | ||
| Q1 24 | $142.4M | $438.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.93× | — | ||
| Q2 24 | 5.38× | — | ||
| Q1 24 | 4.23× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $74.6M | ||
| Q3 25 | $1.3M | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $20.0M | ||
| Q4 24 | $1.6M | $15.2M | ||
| Q3 24 | $5.2M | $9.9M | ||
| Q2 24 | $-5.4M | $33.5M | ||
| Q1 24 | $-1.9M | $45.0M |
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $33.4M | ||
| Q1 24 | — | $44.9M |
| Q4 25 | — | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | — | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 60.0% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BOXL
| Products | $27.4M | 93% |
| Services | $2.0M | 7% |
IRWD
Segment breakdown not available.
